Longitudinal changes in HIV DNA in HIV controllers: what do they mean?
作者信息
Hsu Denise C, Mellors John W
机构信息
Department of Retrovirology, AFRIMS, Bangkok, Thailand.
US Military HIV Research Program, Walter Reed Army Institute of Research, Silver Spring, MD, USA.
出版信息
J Int AIDS Soc. 2019 Feb;22(2):e25254. doi: 10.1002/jia2.25254.
Abstract
摘要
相似文献
1
Longitudinal changes in HIV DNA in HIV controllers: what do they mean?HIV 病毒控制者体内 HIV DNA 的纵向变化：这意味着什么？
J Int AIDS Soc. 2019 Feb;22(2):e25254. doi: 10.1002/jia2.25254.
2
HIV Proviral Burden, Genetic Diversity, and Dynamics in Viremic Controllers Who Subsequently Initiated Suppressive Antiretroviral Therapy.病毒血症控制者中 HIV 前病毒负荷、遗传多样性和动力学，随后启动了抑制性抗逆转录病毒治疗。
mBio. 2021 Dec 21;12(6):e0249021. doi: 10.1128/mBio.02490-21. Epub 2021 Nov 16.
3
Highly divergent patterns of genetic diversity and evolution in proviral quasispecies from HIV controllers.HIV 控制者前病毒准种中高度不同的遗传多样性和进化模式。
Retrovirology. 2017 May 2;14(1):29. doi: 10.1186/s12977-017-0354-5.
4
HIV-DNA content in pTfh cells is associated with residual viremia in elite controllers.滤泡辅助性T细胞中的HIV-DNA含量与精英控制者的残余病毒血症相关。
AIDS. 2021 Mar 1;35(3):393-398. doi: 10.1097/QAD.0000000000002776.
5
Disease Progression in HIV-1-Infected Viremic Controllers.HIV-1 感染者病毒血症中的疾病进展。
J Acquir Immune Defic Syndr. 2012 Dec 1;61(4):407-16. doi: 10.1097/QAI.0b013e318269c414.
6
Case report: mechanisms of HIV elite control in two African women.病例报告：两名非洲女性中 HIV 精英控制的机制。
BMC Infect Dis. 2018 Jan 25;18(1):54. doi: 10.1186/s12879-018-2961-8.
7
Virological characterization of patients treated early is able to control HIV-1 replication after multiple cycles of structured therapy interruption.早期接受治疗的患者的病毒学特征能够在多次结构化治疗中断循环后控制HIV-1复制。
J Med Virol. 2007 Aug;79(8):1047-54. doi: 10.1002/jmv.20895.
8
Elite suppressors have low frequencies of intact HIV-1 proviral DNA.精英抑制者体内完整的HIV-1前病毒DNA频率较低。
AIDS. 2020 Mar 15;34(4):641-643. doi: 10.1097/QAD.0000000000002474.
9
A correlate of HIV-1 control consisting of both innate and adaptive immune parameters best predicts viral load by multivariable analysis in HIV-1 infected viremic controllers and chronically-infected non-controllers.在HIV-1感染的病毒血症控制者和慢性感染者中，通过多变量分析，由先天免疫和适应性免疫参数组成的HIV-1控制相关因素最能预测病毒载量。
PLoS One. 2014 Jul 31;9(7):e103209. doi: 10.1371/journal.pone.0103209. eCollection 2014.
10
Elite and posttreatment controllers, two facets of HIV control.精英控制者和治疗后控制者，HIV 控制的两个方面。
Curr Opin HIV AIDS. 2022 Sep 1;17(5):325-332. doi: 10.1097/COH.0000000000000751. Epub 2022 Jul 25.
本文引用的文献
1
Dynamics in HIV-DNA levels over time in HIV controllers.HIV 感染者中 HIV-DNA 水平随时间的变化动力学。
J Int AIDS Soc. 2019 Jan;22(1):e25221. doi: 10.1002/jia2.25221.
2
Measuring replication competent HIV-1: advances and challenges in defining the latent reservoir.测量复制型 HIV-1：定义潜伏库所面临的挑战与进展。
Retrovirology. 2018 Feb 13;15(1):21. doi: 10.1186/s12977-018-0404-7.
3
HIV DNA Set Point is Rapidly Established in Acute HIV Infection and Dramatically Reduced by Early ART.HIV DNA设定点在急性HIV感染中迅速确立，并通过早期抗逆转录病毒治疗显著降低。
EBioMedicine. 2016 Sep;11:68-72. doi: 10.1016/j.ebiom.2016.07.024. Epub 2016 Jul 20.
4
Multiple Origins of Virus Persistence during Natural Control of HIV Infection.HIV感染自然控制过程中病毒持续存在的多种起源
Cell. 2016 Aug 11;166(4):1004-1015. doi: 10.1016/j.cell.2016.06.039. Epub 2016 Jul 21.
5
Impact of the Timing of Initiation of Antiretroviral Therapy During Primary HIV-1 Infection on the Decay of Cell-Associated HIV-DNA.原发 HIV-1 感染时抗逆转录病毒治疗起始时机对细胞相关 HIV-DNA 衰减的影响。
Clin Infect Dis. 2015 Jun 1;60(11):1715-21. doi: 10.1093/cid/civ171. Epub 2015 Mar 3.
6
An evaluation of HIV elite controller definitions within a large seroconverter cohort collaboration.一项在大型血清转化者队列合作中对HIV精英控制者定义的评估。
PLoS One. 2014 Jan 28;9(1):e86719. doi: 10.1371/journal.pone.0086719. eCollection 2014.
7
Replication-competent noninduced proviruses in the latent reservoir increase barrier to HIV-1 cure.潜伏库中具有复制能力的非诱导前病毒增加了 HIV-1 治愈的障碍。
Cell. 2013 Oct 24;155(3):540-51. doi: 10.1016/j.cell.2013.09.020.
8
Unravelling the mechanisms of durable control of HIV-1.解析 HIV-1 持久控制的机制。
Nat Rev Immunol. 2013 Jul;13(7):487-98. doi: 10.1038/nri3478.
9
Barriers to a cure for HIV: new ways to target and eradicate HIV-1 reservoirs.HIV 治愈障碍：靶向和清除 HIV-1 储存库的新方法。
Lancet. 2013 Jun 15;381(9883):2109-17. doi: 10.1016/S0140-6736(13)60104-X. Epub 2013 Mar 29.
10
Long-term antiretroviral therapy initiated during primary HIV-1 infection is key to achieving both low HIV reservoirs and normal T cell counts.在原发性 HIV-1 感染期间启动长期抗逆转录病毒治疗是实现低 HIV 储存库和正常 T 细胞计数的关键。
J Antimicrob Chemother. 2013 May;68(5):1169-78. doi: 10.1093/jac/dks533. Epub 2013 Jan 20.
Zotero 插件